Stay updated on GX-H9 Clinical Trial in AGHD Safety, Tolerability & Efficacy
Sign up to get notified when there's something new on the GX-H9 Clinical Trial in AGHD Safety, Tolerability & Efficacy page.

Latest updates to the GX-H9 Clinical Trial in AGHD Safety, Tolerability & Efficacy page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 and removal of a temporary government-funding notice, along with the older Revision: v3.4.1; these are routine site maintenance updates that do not affect study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check20 days agoChange DetectedAdded a public notice about potential delays due to a lapse in government funding and updated the site to revision v3.4.1 (removing v3.4.0).SummaryDifference0.4%

- Check28 days agoChange DetectedThese updates are minor UI and metadata changes (Show glossary, Last Update Submitted that Met QC Criteria label, No FEAR Act Data capitalization, revision tag v3.4.0) that do not alter core trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedSite revision updated from v3.3.3 to v3.3.4; no observable changes to study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter updates include adding Revision: v3.3.3 and removing HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision: v3.3.2 is now displayed, replacing the previous v3.2.0.SummaryDifference0.1%

Stay in the know with updates to GX-H9 Clinical Trial in AGHD Safety, Tolerability & Efficacy
Enter your email address, and we'll notify you when there's something new on the GX-H9 Clinical Trial in AGHD Safety, Tolerability & Efficacy page.